Table 3.
Patient and treatment characteristics of the perforation group
| Perforation n (%) | |
|---|---|
| 33 (100) | |
| Age (years) | |
| Under 70 | 24 (72.7) |
| 70 or older | 9 (27.3) |
| Sex | |
| Male | 19 (57.6) |
| Female | 14 (42.4) |
| Diagnosis | |
| Oesophageal cancer-lower | 1 (3.1) |
| Obesity | 3 (9.1) |
| Iatrogenic perforation | 9 (27.3) |
| Boerhaave’s syndrome | 7 (21.2) |
| Other | 13 (39.3) |
| Histology | |
| Squamous cell carcinoma | 3 (9.1) |
| No malignancy | 5 (13.4) |
| Not done | 25 (77.5) |
| Previous treatment | |
| Chemoradiotherapy | 3 (9.1) |
| None | 30 (90.9) |
| Resection type | |
| Oesophagectomy | 3 (9) |
| Endoscopic procedure | 14 (42.5) |
| Gastrectomy | 2 (6) |
| Gastric sleeve resection | 2 (6) |
| Others | 12 (36.5) |
| Reconstruction type | |
| Oesophagogastrostomy | 2 (6) |
| Gastrojejunostomy | 1 (3.1) |
| No reconstruction | 30 (90.9) |
| Site of reconstruction | |
| Intrathoracic | 3 (6.1) |
| Abdominal | 6 (18.2) |
| Cervical | 1 (3.1) |
| No reconstruction | 23 (72.6) |